CONMED Corp CNMD

Healthcare SIC 3845 - Electromedical & Electrotherapeutic Apparatus NAICS Manufacturing › Computer and Electronic Product Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing derived NYSE

Last close 49.25 2026-10-23
Market cap $1.48B 2026-06-30 share count
52-week range 31.44 - 53.66

Valuation FY2025 figures against the last close

P/S1.1x
P/E32.6x
P/FCF9.8x
EV/EBITDA12.3x
Dividend yield1.7%
Diluted EPS1.51

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.37B$1.31B$1.24B$1.05B$1.01B$862.5M$955.1M$859.6M$796.4M$763.5M
Cost of revenue $624.2M$574.0M$568.5M$474.2M$442.6M$402.2M$430.4M$390.5M$365.4M$355.2M
Gross profit $750.5M$733.0M$676.2M$571.2M$568.0M$460.3M$524.7M$469.1M$431.0M$408.3M
R&D $55.9M$54.4M$52.6M$47.2M$43.6M$40.5M$45.5M$42.2M$32.3M$32.3M
SG&A $592.0M$478.3M$503.0M$454.0M$414.8M$373.8M$400.1M$355.6M$351.8M$338.4M
Total operating expenses $647.9M$532.7M$555.6M$501.2M$458.3M$414.3M$445.6M$397.8M$384.1M$370.7M
Operating income $102.6M$200.3M$120.6M$70.1M$109.7M$46.0M$79.1M$71.3M$46.9M$37.7M
Interest expense $31.1M$37.3M$39.8M$28.9M$35.5M$44.1M$42.7M$20.7M$18.2M$15.4M
Pre-tax income $71.1M$163.0M$80.8M-$70.9M$73.1M$1.6M$31.2M$50.7M$28.7M$19.4M
Income tax $24.1M$30.6M$16.4M$9.7M$10.6M$7.9M$2.6M$9.8M$26.8M$4.7M
Net income $47.1M$132.4M$64.5M-$80.6M$62.5M$9.5M$28.6M$40.9M$55.5M$14.7M
EPS, basic 1.524.292.10-2.682.140.331.011.451.990.53
EPS, diluted 1.514.252.04-2.681.940.320.971.411.970.52
Shares, diluted (wtd. avg.) 31.1M31.1M31.5M30.0M32.2M29.5M29.5M28.9M28.2M28.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $40.8M$24.5M$24.3M$28.9M$20.8M$27.4M$25.9M$17.5M$32.6M$27.4M
Receivables $247.8M$237.7M$242.3M$191.3M$183.9M$177.2M$189.1M$181.6M$167.0M$148.2M
Inventory $355.5M$346.7M$318.3M$332.3M$231.6M$194.9M$164.6M$154.6M$141.4M$135.9M
Total current assets $672.9M$640.0M$615.6M$581.2M$460.1M$416.7M$397.4M$374.4M$356.8M$330.5M
Property, plant and equipment $113.3M$115.8M$120.7M$115.6M$108.9M$111.4M$118.9M$113.2M$116.2M$122.0M
Goodwill $807.0M$805.4M$806.8M$815.4M$617.5M$618.4M$618.0M$400.4M$402.0M$397.7M
Other intangibles $582.1M$617.7M$649.5M$681.8M$471.0M$501.5M$532.8M$413.2M$414.9M$419.5M
Total assets $2.33B$2.31B$2.30B$2.30B$1.77B$1.75B$1.78B$1.37B$1.36B$1.33B
Accounts payable $93.6M$102.2M$88.2M$73.4M$58.2M$53.3M$56.0M$53.5M$42.0M$41.6M
Short-term debt ———————$18.3M$14.7M$10.2M
Total current liabilities $315.0M$278.1M$310.7M$296.6M$196.6M$190.2M$188.1M$160.9M$150.0M$114.0M
Long-term debt ———————$438.6M$471.7M$488.3M
Total liabilities $1.29B$1.34B$1.47B$1.55B$980.6M$1.04B$1.06B$706.9M$726.5M$748.4M
Retained earnings $588.8M$560.3M$452.5M$412.6M$496.6M$457.4M$470.8M$464.9M$440.1M$406.9M
Total equity $1.03B$962.7M$834.2M$745.5M$785.4M$709.0M$710.5M$662.3M$631.4M$580.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $170.7M$167.0M$125.3M$33.4M$111.8M$64.5M$95.1M$74.7M$65.6M$39.9M
Depreciation and amortisation $17.1M$16.6M$16.2M$16.1M$16.5M$18.0M$18.7M$18.5M$20.1M$20.5M
Stock-based compensation $28.3M$25.6M$24.3M$21.7M$16.3M$13.1M$11.8M$10.0M$8.5M$8.4M
Capital expenditure $19.8M$13.1M$19.0M$21.8M$14.9M$13.0M$20.1M$16.5M$12.8M$14.8M
Investing cash flow -$21.0M-$13.1M-$20.0M-$249.5M-$14.9M-$13.6M-$387.7M-$16.5M-$29.1M-$266.0M
Financing cash flow -$135.8M-$151.0M-$110.4M$225.0M-$101.5M-$52.1M$300.9M-$72.3M-$34.9M$182.5M
Dividends paid $24.7M$24.7M$24.5M$24.0M$23.3M$22.8M$22.6M$22.4M$22.3M$22.2M
Buybacks —————————$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000816956-26-000047.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B 1.5B Revenue, FY2016: 763.5M Gross profit, FY2016: 408.3M Net income, FY2016: 14.7M Revenue, FY2017: 796.4M Gross profit, FY2017: 431M Net income, FY2017: 55.5M Revenue, FY2018: 859.6M Gross profit, FY2018: 469.1M Net income, FY2018: 40.9M Revenue, FY2019: 955.1M Gross profit, FY2019: 524.7M Net income, FY2019: 28.6M Revenue, FY2020: 862.5M Gross profit, FY2020: 460.3M Net income, FY2020: 9.5M Revenue, FY2021: 1B Gross profit, FY2021: 568M Net income, FY2021: 62.5M Revenue, FY2022: 1B Gross profit, FY2022: 571.2M Net income, FY2022: -80.6M Revenue, FY2023: 1.2B Gross profit, FY2023: 676.2M Net income, FY2023: 64.5M Revenue, FY2024: 1.3B Gross profit, FY2024: 733M Net income, FY2024: 132.4M Revenue, FY2025: 1.4B Gross profit, FY2025: 750.5M Net income, FY2025: 47.1M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $763.5M $796.4M $859.6M $955.1M $862.5M $1.01B $1.05B $1.24B $1.31B $1.37B
Gross profit $408.3M $431.0M $469.1M $524.7M $460.3M $568.0M $571.2M $676.2M $733.0M $750.5M
Net income $14.7M $55.5M $40.9M $28.6M $9.5M $62.5M -$80.6M $64.5M $132.4M $47.1M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement signed Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Officer or director change Item 5.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3845

TickerCompanyMarket capP/ERevenue growth
MDT Medtronic plc $122.04B 25.6x 8.4%
LIVN LivaNova PLC $4.46B — 10.7%
ITGR Integer Holdings Corp $4.30B 43.8x 8.0%
TMDX TransMedics Group, Inc. $2.45B 14.5x 37.1%
AXGN Axogen, Inc. $2.05B — 20.2%
BLFS BIOLIFE SOLUTIONS INC $1.89B — 28.9%
CBLL Ceribell, Inc. $1.04B — 36.1%
CV CapsoVision, Inc $349.8M — 15.3%